Viewing Study NCT00940095

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:42 PM
Ignite Modification Date: 2026-02-01 @ 11:52 PM
Study NCT ID: NCT00940095
Status: TERMINATED
Last Update Posted: 2018-07-09
First Post: 2009-07-13
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Clazosentan in Aneurysmal Subarachnoid Hemorrhage
Sponsor: Idorsia Pharmaceuticals Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Aneurysmal Subarachnoid Hemorrhage View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Subarachnoid View
None Aneurysmal View
None surgical clipping View
None PIVLAZ View
None vasospasm View
None cerebral vasospasm View
None clazosentan View
None Actelion View
None Hemorrhage View